Biomedical Structures (BMS), the developer of biomedical textiles for medical devices and other advanced clinical applications is expanding its facilities in Warwick, Rhode Island, USA.
The company’s Biofelt tissue scaffolds are manufactured from a variety of synthetic, absorbable polymers, including PGA, PLLA, PLGA, and proprietary customer-supplied fibres, as well as other nonwovens.
Nonwoven structures provide greater surface area than most other biomedical textiles, to bring a different set of benefits to implantables. Most notably, the ability to encourage cellular in-growth through specific spacing, layer thickness and material integrity allows for customised performance and controlled absorption profiles. Currently, the company says most device OEMs require nonwoven scaffolds composed of absorbable biomaterials in order to facilitate regrowth before disintegration, but BMS continues to innovate on this model for new filler, gel and other additive applications.
Recommended
Most Popular
Latest Magazine
Features
Nonwovens News talks to Murat Dogru about the upcoming OUTLOOK conference
New line concepts and digital tools are helping nonwovens producers boost output, cut waste and ease labour pressures
New research is exploring the benefits of using PCM impregnated nonwovens for use in composite reinforcements for the construction sector
News
Lenzing to prioritise nonwovens as fibre business reshaped
Turkish yarn manufacturer to enter nonwovens market
Shaping the future of filtration at Filtrex
Other publications from MCL News & Media
